Literature DB >> 14532341

High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections.

Annemarie Borst1, Ad C Fluit1.   

Abstract

Differences in production of two putative virulence factors of Candida albicans, phospholipase and proteinase, were determined for a large panel of clinical C. albicans isolates (n = 186) obtained from the European SENTRY programme. Seventy-two per cent of isolates produced detectable amounts of phospholipase and 95 % of isolates produced detectable amounts of proteinase. There was no clear correlation between the results of the phospholipase and proteinase assays and the geographical distribution of the isolates. However, isolates that originated from respiratory infections produced significantly higher amounts of phospholipase than isolates obtained from blood, the urinary tract or wounds/skin/soft tissue and also appeared to produce more proteinase. These virulent isolates involved in respiratory infections may originate from the oral cavity. Whether these results are caused by selection for these highly virulent isolates remains to be resolved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532341     DOI: 10.1099/jmm.0.05228-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  The Activities of Adhesion and Biofilm Formation by Candida tropicalis Clinical Isolates Display Significant Correlation with Its Multilocus Sequence Typing.

Authors:  Shuan Bao Yu; Wen Ge Li; Xiao Shu Liu; Jie Che; Jin Xing Lu; Yuan Wu
Journal:  Mycopathologia       Date:  2017-01-13       Impact factor: 2.574

2.  Hemolytic activities of the Candida species in liquid medium.

Authors:  Hilal Kuzucu Malcok; Esin Aktas; Ahmet Ayyildiz; Nimet Yigit; Halil Yazgi
Journal:  Eurasian J Med       Date:  2009-08

3.  Investigating biofilm production, coagulase and hemolytic activity in Candida species isolated from denture stomatitis patients.

Authors:  Nimet Yigit; Esin Aktas; Saadettin Dagistan; Ahmet Ayyildiz
Journal:  Eurasian J Med       Date:  2011-04

4.  Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals.

Authors:  Cristiane Yumi Koga-Ito; Juliana Pereira Lyon; Valerio Vidotto; Maria Aparecida de Resende
Journal:  Mycopathologia       Date:  2006-04       Impact factor: 2.574

5.  Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients.

Authors:  C P Girish Kumar; S Suresh Jothi Kumar; Thangam Menon
Journal:  Mycopathologia       Date:  2006-04       Impact factor: 2.574

6.  Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.

Authors:  Sourour Neji; Ines Hadrich; Houaida Trabelsi; Salma Abbes; Fatma Cheikhrouhou; Hayet Sellami; Fattouma Makni; Ali Ayadi
Journal:  J Biomed Sci       Date:  2017-09-04       Impact factor: 8.410

7.  Estimation of biofilm, proteinase & phospholipase production of the Candida species isolated from the oropharyngeal samples in HIV-infected patients.

Authors:  Vicky Lahkar; Lahari Saikia; Saurav J Patgiri; Reema Nath; Partha Pratim Das
Journal:  Indian J Med Res       Date:  2017-05       Impact factor: 2.375

8.  Different Candida parapsilosis clinical isolates and lipase deficient strain trigger an altered cellular immune response.

Authors:  Renáta Tóth; Maria F Alonso; Judith M Bain; Csaba Vágvölgyi; Lars-Peter Erwig; Attila Gácser
Journal:  Front Microbiol       Date:  2015-10-13       Impact factor: 5.640

9.  Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile.

Authors:  Sachin C Deorukhkar; Santosh Saini; Stephen Mathew
Journal:  Int J Microbiol       Date:  2014-04-02

10.  Virulence factors of Candida species isolated from patients with urinary tract infection and obstructive uropathy.

Authors:  Faris Q B Alenzi
Journal:  Pak J Med Sci       Date:  2016 Jan-Feb       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.